It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2020.
2020 | Ahmedabad, Gujarat, India | ActiveUlterius Pharmaceuticals Private Limited, a active private limited company, was established on 02 May 2020 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239GJ2020PTC113520. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 3 professional, Its leadership includes Devanshi Vijay Thakkar (Director), Bansi Pujara (Director), Sanjay Muljibhai Thakkar (Director). Past directors included Devanshi Vijay Thakkar, Bansi Pujara. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 806, Samudra Annexy, Nr. Classic Gold, Opp. Shantanu, Navrangpura, Ahmedabad, Gujarat, 380009.
U24239GJ2020PTC113520
113520
02 May 2020
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Ulterius Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devanshi Vijay Thakkar | Director | 22 Jul 2020 | Current |
| Bansi Pujara | Director | 30 Jun 2020 | Current |
| Sanjay Muljibhai Thakkar | Director | 02 May 2020 | Current |
| Sangeet Sanjaykumar Thakkar | Director | 02 May 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ulterius Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ulterius Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ulterius Pharmaceuticals has a workforce of 3 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ulterius Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ulterius Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ulterius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Ulterius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Devanshi Vijay Thakkar was appointed as a Director was appointed as a Director on 22 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
Bansi Pujara was appointed as a Director was appointed as a Director on 30 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Sanjay Muljibhai Thakkar was appointed as a Director was appointed as a Director on 02 May 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.
Progress on Sangeet Sanjaykumar Thakkar was appointed as a Director was appointed as a Director on 02 May 2020 & has been associated with this company since 5 years 7 months . was documented.
The CIN of Ulterius Pharmaceuticals Private Limited is U24239GJ2020PTC113520.
Ulterius Pharmaceuticals Private Limited is headquartered at 806, Samudra Annexy, Nr. Classic Gold, Opp. Shantanu, Navrangpura, Ahmedabad, Gujarat, 380009.
Ulterius Pharmaceuticals Private Limited was incorporated on 02 May 2020.
The current directors of Ulterius Pharmaceuticals Private Limited are
The primary industry of Ulterius Pharmaceuticals Private Limited is Pharma.
Ulterius Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ulterius Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX